Show Nav →
Please include the following statement when referencing the CPTAC Assay Portal
We would like to acknowledge the National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) Assay Portal (assays.cancer.gov) for developing assays and establishing criteria for the assays described in this publication.

Overview Data source: UniProt

Official Gene Symbol Other Aliases
RAD23B N/A
Sequence Length (AA) Molecular Weight (Da)
409 43171
Protein Name
UV excision repair protein RAD23 homolog B
Sources
UniProt
PhosphoSitePlus ®
GeneCards
Human Protein Atlas

Protein Sequence hover to view complete sequence

10 20 30 40 50
MQVTLKTLQQ QTFKIDIDPE ETVKALKEKI ESEKGKDAFP VAGQKLIYAG
60 70 80 90 100
KILNDDTALK EYKIDEKNFV VVMVTKPKAV STPAPATTQQ SAPASTTAVT
110 120 130 140 150
SSTTTTVAQA PTPVPALAPT STPASITPAS ATASSEPAPA SAAKQEKPAE
160 170 180 190 200
KPAETPVATS PTATDSTSGD SSRSNLFEDA TSALVTGQSY ENMVTEIMSM
210 220 230 240 250
GYEREQVIAA LRASFNNPDR AVEYLLMGIP GDRESQAVVD PPQAASTGAP
260 270 280 290 300
QSSAVAAAAA TTTATTTTTS SGGHPLEFLR NQPQFQQMRQ IIQQNPSLLP
310 320 330 340 350
ALLQQIGREN PQLLQQISQH QEHFIQMLNE PVQEAGGQGG GGGGGSGGIA
360 370 380 390 400
EAGSGHMNYI QVTPQEKEAI ERLKALGFPE GLVIQAYFAC EKNENLAANF
409
LLQQNFDED

Data source: UniProt


Position of Targeted Peptide Analytes Relative to SNPs, Isoforms, and PTMs

Uniprot Database Entry PhosphoSitePlus ®

Click a point on a node
to view detailed assay information below
All other points link out to UniProt



Phosphorylation Acetylation Ubiquitylation Other

loading

Loader

Assay Details for CPTAC-1456 Collapse assay details

Data source: Panorama

Official Gene Symbol
RAD23B
Peptide Sequence
EQVIAALR
Modification Type
unmodified
Protein - Site of Modification
N/A
Peptide - Site of Modification
N/A
Peptide Start
205
Peptide End
212
CPTAC ID
CPTAC-1456
Peptide Molecular Mass
898.5236
Species
Homo sapiens (Human)
Assay Type
Direct MRM
Matrix
depleted digested plasma
Submitting Laboratory
Broad Institute
Submitting Lab PI
Steven A. Carr

Publication

View Details (opens in a new window)

Large-Scale Interlaboratory Study to Develop, Analytically Validate and Apply Highly Multiplexed, Quantitative Peptide Assays to Measure Cancer-Relevant Proteins in Plasma. Abbatiello SE, Schilling B, Mani DR, Zimmerman LJ, Hall SC, MacLean B, Albertolle M, Allen S, Burgess M, Cusack MP, Gosh M, Hedrick V, Held JM, Inerowicz HD, Jackson A, Keshishian H, Kinsinger CR, Lyssand J, Makowski L, Mesri M, Rodriguez H, Rudnick P, Sadowski P, Sedransk N, Shaddox K, Skates SJ, Kuhn E, Smith D, Whiteaker JR, Whitwell C, Zhang S, Borchers CH, Fisher SJ, Gibson BW, Liebler DC, MacCoss MJ, Neubert TA, Paulovich AG, Regnier FE, Tempst P, Carr SA. Mol Cell Proteomics. 2015 Sep;14(9):2357-74. doi: 10.1074/mcp.M114.047050. Epub 2015 Feb 18. PMID: 25693799


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument
Quantiva TSQ
Internal Standard
heavy stable isotope peptide (delta 8-10)
Peptide Standard Purity
>95%
Peptide Standard Label Type
15N
LC
Easy NanoLC1000
Column Packing
Reprosil C18, 1.9um, 200A
Column Dimensions
0.075 x 150 mm
Flow Rate
200 nL/min

Assay Multiplexing Expand assay panel

Broad Institute-Plasma-based Candidate Cancer Biomarkers

CPTAC-1372:
ALDOC.
ALQASALNAWR
CPTAC-1373:
ALDOC.
AEVNGLAAQGK
CPTAC-1374:
ALDOC.
ELSDIALR
CPTAC-1375:
ALDOC.
TPSALAILENANVLAR
CPTAC-1376:
ALDOC.
QVLFSADDR
CPTAC-1377:
ANXA1.
ALYEAGER
CPTAC-1378:
ANXA1.
GTDVNVFNTILTTR
CPTAC-1379:
ANXA1.
AAYLQETGKPLDETLK
CPTAC-1380:
ANXA1.
TPAQFDADELR
CPTAC-1381:
ANXA4.
VLVSLSAGGR
CPTAC-1382:
ANXA4.
GLGTDEDAIISVLAYR
CPTAC-1383:
ANXA4.
DEGNYLDDALVR
CPTAC-1384:
ANXA4.
GAGTDEGC[+57.0]LIEILASR
CPTAC-1385:
ANXA7.
LYQAGEGR
CPTAC-1386:
ANXA7.
SEIDLVQIK
CPTAC-1387:
ANXA7.
GAGTDDSTLVR
CPTAC-1388:
ANXA7.
EFSGYVESGLK
CPTAC-1389:
ANXA7.
GFGTDEQAIVDVVANR
CPTAC-1390:
CALR.
QIDNPDYK
CPTAC-1391:
CALR.
FYALSASFEPFSNK
CPTAC-1392:
CALR.
EQFLDGDGWTSR
CPTAC-1393:
CLIC1.
LHIVQVVC[+57.0]K
CPTAC-1394:
CLIC1.
YLSNAYAR
CPTAC-1395:
CLIC1.
IEEFLEAVLC[+57.0]PPR
CPTAC-1396:
CLIC1.
GVTFNVTTVDTK
CPTAC-1397:
CLIC1.
GFTIPEAFR
CPTAC-1398:
EZR.
IQVWHAEHR
CPTAC-1399:
EZR.
EDEVEEWQHR
CPTAC-1400:
EZR.
SGYLSSER
CPTAC-1401:
EZR.
IALLEEAR
CPTAC-1402:
EZR.
SQEQLAAELAEYTAK
CPTAC-1403:
FSCN1.
FLIVAHDDGR
CPTAC-1404:
FSCN1.
YLAPSGPSGTLK
CPTAC-1405:
FSCN1.
VTGTLDANR
CPTAC-1406:
FSCN1.
LSC[+57.0]FAQTVSPAEK
CPTAC-1407:
FTL.
LGGPEAGLGEYLFER
CPTAC-1408:
FTL.
KPAEDEWGK
CPTAC-1409:
FEN1.
SIEEIVR
CPTAC-1410:
FEN1.
QLQQAQAAGAEQEVEK
CPTAC-1411:
FEN1.
LIADVAPSAIR
CPTAC-1412:
GSTP1.
FQDGDLTLYQSNTILR
CPTAC-1413:
GSTP1.
EEVVTVETWQEGSLK
CPTAC-1414:
GSTP1.
PPYTVVYFPVR
CPTAC-1415:
GSTP1.
ASC[+57.0]LYGQLPK
CPTAC-1416:
GLO1.
FSLYFLAYEDK
CPTAC-1417:
GLO1.
SLDFYTR
CPTAC-1418:
GLO1.
IAWALSR
CPTAC-1419:
GLO1.
GFGHIGIAVPDVYSAC[+57.0]K
CPTAC-1420:
GLO1.
FEELGVK
CPTAC-1421:
GRB2.
FNSLNELVDYHR
CPTAC-1422:
GRB2.
FGNDVQHFK
CPTAC-1423:
GRB2.
NYVTPVNR
CPTAC-1424:
GRB2.
ATADDELSFK
CPTAC-1425:
GRB2.
ESESAPGDFSLSVK
CPTAC-1426:
HSPB1.
LFDQAFGLPR
CPTAC-1427:
HSPB1.
AQLGGPEAAK
CPTAC-1428:
HSPB1.
VSLDVNHFAPDELTVK
CPTAC-1429:
HSPB1.
DGVVEITGK
CPTAC-1430:
HSPB1.
QLSSGVSEIR
CPTAC-1431:
IL18.
EDELGDR
CPTAC-1432:
IL18.
SDIIFFQR
CPTAC-1433:
IL18.
TIFIISMYK
CPTAC-1434:
IL18.
ISTLSC[+57.0]ENK
CPTAC-1435:
IL18.
GMAVTISVK
CPTAC-1436:
LGALS1.
DGGAWGTEQR
CPTAC-1437:
LGALS1.
DSNNLC[+57.0]LHFNPR
CPTAC-1438:
LGALS1.
FNAHGDANTIVC[+57.0]NSK
CPTAC-1439:
LGALS1.
SFVLNLGK
CPTAC-1440:
LGALS1.
LPDGYEFK
CPTAC-1441:
PDLIM1.
C[+57.0]GTGIVGVFVK
CPTAC-1442:
PDLIM1.
VAASIGNAQK
CPTAC-1443:
PDLIM1.
VWSPLVTEEGK
CPTAC-1444:
PDLIM1.
DFEQPLAISR
CPTAC-1445:
PRDX2.
GLFIIDGK
CPTAC-1446:
PRDX2.
TDEGIAYR
CPTAC-1447:
PRDX2.
ATAVVDGAFK
CPTAC-1448:
PRDX4.
DYGVYLEDSGHTLR
CPTAC-1449:
PRDX4.
LVQAFQYTDK
CPTAC-1450:
PRDX4.
IPLLSDLTHQISK
CPTAC-1451:
PRDX4.
QITLNDLPVGR
CPTAC-1452:
S100A1.
ELLQTELSGFLDAQK
CPTAC-1453:
S100A2.
ELPSFVGEK
CPTAC-1454:
S100B.
AMVALIDVFHQYSGR
CPTAC-1455:
S100B.
ELINNELSHFLEEIK
CPTAC-1456:
RAD23B.
EQVIAALR
CPTAC-1457:
RAD23B.
IDIDPEETVK
CPTAC-1458:
RAD23B.
ILNDDTALK
CPTAC-1459:
SNCG.
EGVVGAVEK
CPTAC-1460:
SNCG.
ENVVQSVTSVAEK
CPTAC-1461:
SNCG.
TVEEAENIAVTSGVVR
CPTAC-1462:
TPM1.
LVIIESDLER
CPTAC-1463:
TPM1.
SIDDLEDELYAQK
CPTAC-1464:
TPM1.
QLEDELVSLQK
CPTAC-1465:
UBE2C.
YLQETYSK
CPTAC-1466:
UBE2C.
LSLEFPSGYPYNAPTVK
CPTAC-1467:
UBE2C.
DPAATSVAAAR
CPTAC-1468:
UBE2C.
GISAFPESDNLFK
CPTAC-1469:
UBE2I.
DDYPSSPPK
CPTAC-1470:
UBE2I.
DWRPAITIK
CPTAC-1471:
UBE2I.
DHPFGFVAVPTK

Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader

Repeatability

Data source: Panorama

  Average intra-assay CV
(within day CV)
Average inter-assay CV
(between day CV)
Total CV
equation
n=
Fragment ion / Transition Low Med High Low Med High Low Med High Low Med High
y5 (1+) 2.7 1.5 1.7 4.6 6.9 3.3 5.3 7.1 3.7 15 15 15
y4 (1+) 1.7 1.9 1.2 3 6.4 2.8 3.4 6.7 3 15 15 15
y6 (1+) 3.1 2.6 3 5.4 6.3 3.8 6.2 6.8 4.8 15 15 15
sum 1.5 1.7 1.3 3.7 6.5 2.9 4 6.7 3.2 15 15 15


Additional Resources and Comments


Assay Details for CPTAC-1457 Collapse assay details

Data source: Panorama

Official Gene Symbol
RAD23B
Peptide Sequence
IDIDPEETVK
Modification Type
unmodified
Protein - Site of Modification
N/A
Peptide - Site of Modification
N/A
Peptide Start
15
Peptide End
24
CPTAC ID
CPTAC-1457
Peptide Molecular Mass
1,157.5816
Species
Homo sapiens (Human)
Assay Type
Direct MRM
Matrix
depleted digested plasma
Submitting Laboratory
Broad Institute
Submitting Lab PI
Steven A. Carr

Publication

View Details (opens in a new window)

Large-Scale Interlaboratory Study to Develop, Analytically Validate and Apply Highly Multiplexed, Quantitative Peptide Assays to Measure Cancer-Relevant Proteins in Plasma. Abbatiello SE, Schilling B, Mani DR, Zimmerman LJ, Hall SC, MacLean B, Albertolle M, Allen S, Burgess M, Cusack MP, Gosh M, Hedrick V, Held JM, Inerowicz HD, Jackson A, Keshishian H, Kinsinger CR, Lyssand J, Makowski L, Mesri M, Rodriguez H, Rudnick P, Sadowski P, Sedransk N, Shaddox K, Skates SJ, Kuhn E, Smith D, Whiteaker JR, Whitwell C, Zhang S, Borchers CH, Fisher SJ, Gibson BW, Liebler DC, MacCoss MJ, Neubert TA, Paulovich AG, Regnier FE, Tempst P, Carr SA. Mol Cell Proteomics. 2015 Sep;14(9):2357-74. doi: 10.1074/mcp.M114.047050. Epub 2015 Feb 18. PMID: 25693799


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument
Quantiva TSQ
Internal Standard
heavy stable isotope peptide (delta 8-10)
Peptide Standard Purity
>95%
Peptide Standard Label Type
13C and 15N at C-terminus K
LC
Easy NanoLC1000
Column Packing
Reprosil C18, 1.9um, 200A
Column Dimensions
0.075 x 150 mm
Flow Rate
200 nL/min

Assay Multiplexing Expand assay panel

Broad Institute-Plasma-based Candidate Cancer Biomarkers

CPTAC-1372:
ALDOC.
ALQASALNAWR
CPTAC-1373:
ALDOC.
AEVNGLAAQGK
CPTAC-1374:
ALDOC.
ELSDIALR
CPTAC-1375:
ALDOC.
TPSALAILENANVLAR
CPTAC-1376:
ALDOC.
QVLFSADDR
CPTAC-1377:
ANXA1.
ALYEAGER
CPTAC-1378:
ANXA1.
GTDVNVFNTILTTR
CPTAC-1379:
ANXA1.
AAYLQETGKPLDETLK
CPTAC-1380:
ANXA1.
TPAQFDADELR
CPTAC-1381:
ANXA4.
VLVSLSAGGR
CPTAC-1382:
ANXA4.
GLGTDEDAIISVLAYR
CPTAC-1383:
ANXA4.
DEGNYLDDALVR
CPTAC-1384:
ANXA4.
GAGTDEGC[+57.0]LIEILASR
CPTAC-1385:
ANXA7.
LYQAGEGR
CPTAC-1386:
ANXA7.
SEIDLVQIK
CPTAC-1387:
ANXA7.
GAGTDDSTLVR
CPTAC-1388:
ANXA7.
EFSGYVESGLK
CPTAC-1389:
ANXA7.
GFGTDEQAIVDVVANR
CPTAC-1390:
CALR.
QIDNPDYK
CPTAC-1391:
CALR.
FYALSASFEPFSNK
CPTAC-1392:
CALR.
EQFLDGDGWTSR
CPTAC-1393:
CLIC1.
LHIVQVVC[+57.0]K
CPTAC-1394:
CLIC1.
YLSNAYAR
CPTAC-1395:
CLIC1.
IEEFLEAVLC[+57.0]PPR
CPTAC-1396:
CLIC1.
GVTFNVTTVDTK
CPTAC-1397:
CLIC1.
GFTIPEAFR
CPTAC-1398:
EZR.
IQVWHAEHR
CPTAC-1399:
EZR.
EDEVEEWQHR
CPTAC-1400:
EZR.
SGYLSSER
CPTAC-1401:
EZR.
IALLEEAR
CPTAC-1402:
EZR.
SQEQLAAELAEYTAK
CPTAC-1403:
FSCN1.
FLIVAHDDGR
CPTAC-1404:
FSCN1.
YLAPSGPSGTLK
CPTAC-1405:
FSCN1.
VTGTLDANR
CPTAC-1406:
FSCN1.
LSC[+57.0]FAQTVSPAEK
CPTAC-1407:
FTL.
LGGPEAGLGEYLFER
CPTAC-1408:
FTL.
KPAEDEWGK
CPTAC-1409:
FEN1.
SIEEIVR
CPTAC-1410:
FEN1.
QLQQAQAAGAEQEVEK
CPTAC-1411:
FEN1.
LIADVAPSAIR
CPTAC-1412:
GSTP1.
FQDGDLTLYQSNTILR
CPTAC-1413:
GSTP1.
EEVVTVETWQEGSLK
CPTAC-1414:
GSTP1.
PPYTVVYFPVR
CPTAC-1415:
GSTP1.
ASC[+57.0]LYGQLPK
CPTAC-1416:
GLO1.
FSLYFLAYEDK
CPTAC-1417:
GLO1.
SLDFYTR
CPTAC-1418:
GLO1.
IAWALSR
CPTAC-1419:
GLO1.
GFGHIGIAVPDVYSAC[+57.0]K
CPTAC-1420:
GLO1.
FEELGVK
CPTAC-1421:
GRB2.
FNSLNELVDYHR
CPTAC-1422:
GRB2.
FGNDVQHFK
CPTAC-1423:
GRB2.
NYVTPVNR
CPTAC-1424:
GRB2.
ATADDELSFK
CPTAC-1425:
GRB2.
ESESAPGDFSLSVK
CPTAC-1426:
HSPB1.
LFDQAFGLPR
CPTAC-1427:
HSPB1.
AQLGGPEAAK
CPTAC-1428:
HSPB1.
VSLDVNHFAPDELTVK
CPTAC-1429:
HSPB1.
DGVVEITGK
CPTAC-1430:
HSPB1.
QLSSGVSEIR
CPTAC-1431:
IL18.
EDELGDR
CPTAC-1432:
IL18.
SDIIFFQR
CPTAC-1433:
IL18.
TIFIISMYK
CPTAC-1434:
IL18.
ISTLSC[+57.0]ENK
CPTAC-1435:
IL18.
GMAVTISVK
CPTAC-1436:
LGALS1.
DGGAWGTEQR
CPTAC-1437:
LGALS1.
DSNNLC[+57.0]LHFNPR
CPTAC-1438:
LGALS1.
FNAHGDANTIVC[+57.0]NSK
CPTAC-1439:
LGALS1.
SFVLNLGK
CPTAC-1440:
LGALS1.
LPDGYEFK
CPTAC-1441:
PDLIM1.
C[+57.0]GTGIVGVFVK
CPTAC-1442:
PDLIM1.
VAASIGNAQK
CPTAC-1443:
PDLIM1.
VWSPLVTEEGK
CPTAC-1444:
PDLIM1.
DFEQPLAISR
CPTAC-1445:
PRDX2.
GLFIIDGK
CPTAC-1446:
PRDX2.
TDEGIAYR
CPTAC-1447:
PRDX2.
ATAVVDGAFK
CPTAC-1448:
PRDX4.
DYGVYLEDSGHTLR
CPTAC-1449:
PRDX4.
LVQAFQYTDK
CPTAC-1450:
PRDX4.
IPLLSDLTHQISK
CPTAC-1451:
PRDX4.
QITLNDLPVGR
CPTAC-1452:
S100A1.
ELLQTELSGFLDAQK
CPTAC-1453:
S100A2.
ELPSFVGEK
CPTAC-1454:
S100B.
AMVALIDVFHQYSGR
CPTAC-1455:
S100B.
ELINNELSHFLEEIK
CPTAC-1456:
RAD23B.
EQVIAALR
CPTAC-1457:
RAD23B.
IDIDPEETVK
CPTAC-1458:
RAD23B.
ILNDDTALK
CPTAC-1459:
SNCG.
EGVVGAVEK
CPTAC-1460:
SNCG.
ENVVQSVTSVAEK
CPTAC-1461:
SNCG.
TVEEAENIAVTSGVVR
CPTAC-1462:
TPM1.
LVIIESDLER
CPTAC-1463:
TPM1.
SIDDLEDELYAQK
CPTAC-1464:
TPM1.
QLEDELVSLQK
CPTAC-1465:
UBE2C.
YLQETYSK
CPTAC-1466:
UBE2C.
LSLEFPSGYPYNAPTVK
CPTAC-1467:
UBE2C.
DPAATSVAAAR
CPTAC-1468:
UBE2C.
GISAFPESDNLFK
CPTAC-1469:
UBE2I.
DDYPSSPPK
CPTAC-1470:
UBE2I.
DWRPAITIK
CPTAC-1471:
UBE2I.
DHPFGFVAVPTK

Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader

Repeatability

Data source: Panorama

  Average intra-assay CV
(within day CV)
Average inter-assay CV
(between day CV)
Total CV
equation
n=
Fragment ion / Transition Low Med High Low Med High Low Med High Low Med High
y6 (1+) 3.9 1.7 1.2 7.7 6.4 2.2 8.6 6.6 2.5 15 15 15
y8 (1+) 4.3 1.9 2.1 6.1 6.9 3.8 7.5 7.2 4.3 15 15 15
y7 (1+) 5 2.1 1.4 9.3 6.4 3.5 10.6 6.7 3.8 15 15 15
sum 2.6 1.4 0.9 7.3 6.4 2.6 7.7 6.6 2.8 15 15 15


Additional Resources and Comments


Assay Details for CPTAC-1458 Collapse assay details

Data source: Panorama

Official Gene Symbol
RAD23B
Peptide Sequence
ILNDDTALK
Modification Type
unmodified
Protein - Site of Modification
N/A
Peptide - Site of Modification
N/A
Peptide Start
52
Peptide End
60
CPTAC ID
CPTAC-1458
Peptide Molecular Mass
1,001.5393
Species
Homo sapiens (Human)
Assay Type
Direct MRM
Matrix
depleted digested plasma
Submitting Laboratory
Broad Institute
Submitting Lab PI
Steven A. Carr

Publication

View Details (opens in a new window)

Large-Scale Interlaboratory Study to Develop, Analytically Validate and Apply Highly Multiplexed, Quantitative Peptide Assays to Measure Cancer-Relevant Proteins in Plasma. Abbatiello SE, Schilling B, Mani DR, Zimmerman LJ, Hall SC, MacLean B, Albertolle M, Allen S, Burgess M, Cusack MP, Gosh M, Hedrick V, Held JM, Inerowicz HD, Jackson A, Keshishian H, Kinsinger CR, Lyssand J, Makowski L, Mesri M, Rodriguez H, Rudnick P, Sadowski P, Sedransk N, Shaddox K, Skates SJ, Kuhn E, Smith D, Whiteaker JR, Whitwell C, Zhang S, Borchers CH, Fisher SJ, Gibson BW, Liebler DC, MacCoss MJ, Neubert TA, Paulovich AG, Regnier FE, Tempst P, Carr SA. Mol Cell Proteomics. 2015 Sep;14(9):2357-74. doi: 10.1074/mcp.M114.047050. Epub 2015 Feb 18. PMID: 25693799


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument
Quantiva TSQ
Internal Standard
heavy stable isotope peptide (delta 8-10)
Peptide Standard Purity
>95%
Peptide Standard Label Type
13C and 15N at C-terminus K
LC
Easy NanoLC1000
Column Packing
Reprosil C18, 1.9um, 200A
Column Dimensions
0.075 x 150 mm
Flow Rate
200 nL/min

Assay Multiplexing Expand assay panel

Broad Institute-Plasma-based Candidate Cancer Biomarkers

CPTAC-1372:
ALDOC.
ALQASALNAWR
CPTAC-1373:
ALDOC.
AEVNGLAAQGK
CPTAC-1374:
ALDOC.
ELSDIALR
CPTAC-1375:
ALDOC.
TPSALAILENANVLAR
CPTAC-1376:
ALDOC.
QVLFSADDR
CPTAC-1377:
ANXA1.
ALYEAGER
CPTAC-1378:
ANXA1.
GTDVNVFNTILTTR
CPTAC-1379:
ANXA1.
AAYLQETGKPLDETLK
CPTAC-1380:
ANXA1.
TPAQFDADELR
CPTAC-1381:
ANXA4.
VLVSLSAGGR
CPTAC-1382:
ANXA4.
GLGTDEDAIISVLAYR
CPTAC-1383:
ANXA4.
DEGNYLDDALVR
CPTAC-1384:
ANXA4.
GAGTDEGC[+57.0]LIEILASR
CPTAC-1385:
ANXA7.
LYQAGEGR
CPTAC-1386:
ANXA7.
SEIDLVQIK
CPTAC-1387:
ANXA7.
GAGTDDSTLVR
CPTAC-1388:
ANXA7.
EFSGYVESGLK
CPTAC-1389:
ANXA7.
GFGTDEQAIVDVVANR
CPTAC-1390:
CALR.
QIDNPDYK
CPTAC-1391:
CALR.
FYALSASFEPFSNK
CPTAC-1392:
CALR.
EQFLDGDGWTSR
CPTAC-1393:
CLIC1.
LHIVQVVC[+57.0]K
CPTAC-1394:
CLIC1.
YLSNAYAR
CPTAC-1395:
CLIC1.
IEEFLEAVLC[+57.0]PPR
CPTAC-1396:
CLIC1.
GVTFNVTTVDTK
CPTAC-1397:
CLIC1.
GFTIPEAFR
CPTAC-1398:
EZR.
IQVWHAEHR
CPTAC-1399:
EZR.
EDEVEEWQHR
CPTAC-1400:
EZR.
SGYLSSER
CPTAC-1401:
EZR.
IALLEEAR
CPTAC-1402:
EZR.
SQEQLAAELAEYTAK
CPTAC-1403:
FSCN1.
FLIVAHDDGR
CPTAC-1404:
FSCN1.
YLAPSGPSGTLK
CPTAC-1405:
FSCN1.
VTGTLDANR
CPTAC-1406:
FSCN1.
LSC[+57.0]FAQTVSPAEK
CPTAC-1407:
FTL.
LGGPEAGLGEYLFER
CPTAC-1408:
FTL.
KPAEDEWGK
CPTAC-1409:
FEN1.
SIEEIVR
CPTAC-1410:
FEN1.
QLQQAQAAGAEQEVEK
CPTAC-1411:
FEN1.
LIADVAPSAIR
CPTAC-1412:
GSTP1.
FQDGDLTLYQSNTILR
CPTAC-1413:
GSTP1.
EEVVTVETWQEGSLK
CPTAC-1414:
GSTP1.
PPYTVVYFPVR
CPTAC-1415:
GSTP1.
ASC[+57.0]LYGQLPK
CPTAC-1416:
GLO1.
FSLYFLAYEDK
CPTAC-1417:
GLO1.
SLDFYTR
CPTAC-1418:
GLO1.
IAWALSR
CPTAC-1419:
GLO1.
GFGHIGIAVPDVYSAC[+57.0]K
CPTAC-1420:
GLO1.
FEELGVK
CPTAC-1421:
GRB2.
FNSLNELVDYHR
CPTAC-1422:
GRB2.
FGNDVQHFK
CPTAC-1423:
GRB2.
NYVTPVNR
CPTAC-1424:
GRB2.
ATADDELSFK
CPTAC-1425:
GRB2.
ESESAPGDFSLSVK
CPTAC-1426:
HSPB1.
LFDQAFGLPR
CPTAC-1427:
HSPB1.
AQLGGPEAAK
CPTAC-1428:
HSPB1.
VSLDVNHFAPDELTVK
CPTAC-1429:
HSPB1.
DGVVEITGK
CPTAC-1430:
HSPB1.
QLSSGVSEIR
CPTAC-1431:
IL18.
EDELGDR
CPTAC-1432:
IL18.
SDIIFFQR
CPTAC-1433:
IL18.
TIFIISMYK
CPTAC-1434:
IL18.
ISTLSC[+57.0]ENK
CPTAC-1435:
IL18.
GMAVTISVK
CPTAC-1436:
LGALS1.
DGGAWGTEQR
CPTAC-1437:
LGALS1.
DSNNLC[+57.0]LHFNPR
CPTAC-1438:
LGALS1.
FNAHGDANTIVC[+57.0]NSK
CPTAC-1439:
LGALS1.
SFVLNLGK
CPTAC-1440:
LGALS1.
LPDGYEFK
CPTAC-1441:
PDLIM1.
C[+57.0]GTGIVGVFVK
CPTAC-1442:
PDLIM1.
VAASIGNAQK
CPTAC-1443:
PDLIM1.
VWSPLVTEEGK
CPTAC-1444:
PDLIM1.
DFEQPLAISR
CPTAC-1445:
PRDX2.
GLFIIDGK
CPTAC-1446:
PRDX2.
TDEGIAYR
CPTAC-1447:
PRDX2.
ATAVVDGAFK
CPTAC-1448:
PRDX4.
DYGVYLEDSGHTLR
CPTAC-1449:
PRDX4.
LVQAFQYTDK
CPTAC-1450:
PRDX4.
IPLLSDLTHQISK
CPTAC-1451:
PRDX4.
QITLNDLPVGR
CPTAC-1452:
S100A1.
ELLQTELSGFLDAQK
CPTAC-1453:
S100A2.
ELPSFVGEK
CPTAC-1454:
S100B.
AMVALIDVFHQYSGR
CPTAC-1455:
S100B.
ELINNELSHFLEEIK
CPTAC-1456:
RAD23B.
EQVIAALR
CPTAC-1457:
RAD23B.
IDIDPEETVK
CPTAC-1458:
RAD23B.
ILNDDTALK
CPTAC-1459:
SNCG.
EGVVGAVEK
CPTAC-1460:
SNCG.
ENVVQSVTSVAEK
CPTAC-1461:
SNCG.
TVEEAENIAVTSGVVR
CPTAC-1462:
TPM1.
LVIIESDLER
CPTAC-1463:
TPM1.
SIDDLEDELYAQK
CPTAC-1464:
TPM1.
QLEDELVSLQK
CPTAC-1465:
UBE2C.
YLQETYSK
CPTAC-1466:
UBE2C.
LSLEFPSGYPYNAPTVK
CPTAC-1467:
UBE2C.
DPAATSVAAAR
CPTAC-1468:
UBE2C.
GISAFPESDNLFK
CPTAC-1469:
UBE2I.
DDYPSSPPK
CPTAC-1470:
UBE2I.
DWRPAITIK
CPTAC-1471:
UBE2I.
DHPFGFVAVPTK

Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader

Repeatability

Data source: Panorama

  Average intra-assay CV
(within day CV)
Average inter-assay CV
(between day CV)
Total CV
equation
n=
Fragment ion / Transition Low Med High Low Med High Low Med High Low Med High
y7 (1+) 2.2 2 1 2.9 5.8 2.9 3.6 6.1 3.1 15 15 15
y8 (1+) 3 2.2 1.3 4.5 6.8 3.6 5.4 7.1 3.8 15 15 15
y6 (1+) 3.9 2.6 1.4 5.3 6.2 3.5 6.6 6.7 3.8 15 15 15
sum 2 1.9 0.9 2.8 6 3.1 3.4 6.3 3.2 15 15 15


Additional Resources and Comments


Assay Details for CPTAC-707 Collapse assay details

Data source: Panorama

Official Gene Symbol
RAD23B
Peptide Sequence
IDIDPEETVK
Modification Type
unmodified
Protein - Site of Modification
N/A
Peptide - Site of Modification
N/A
Peptide Start
15
Peptide End
24
CPTAC ID
CPTAC-707
Peptide Molecular Mass
1,157.5816
Species
Homo sapiens (Human)
Assay Type
Enrichment MRM
Enrichment Method
N/A
Matrix
plasma
Submitting Laboratory
Fred Hutchinson Cancer Research Center
Submitting Lab PI
Amanda Paulovich

Publication

View Details (opens in a new window)

Anti-peptide monoclonal antibodies generated for immuno-multiple reaction monitoring-mass spectrometry assays have a high probability of supporting Western blot and ELISA. Schoenherr RM, Saul RG, Whiteaker JR, Yan P, Whiteley GR, Paulovich AG. Mol Cell Proteomics. 2015 Feb;14(2):382-98. doi: 10.1074/mcp.O114.043133. Epub 2014 Dec 15. PMID: 25512614


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument
5500 Qtrap
Internal Standard
synthetic peptide
Peptide Standard Purity
>95%
Peptide Standard Label Type
13C and 15N at C-terminus K
LC
Eksigent NanoLC 2D
Column Packing
ReproSil-Pur C18-AQ 3 um
Column Dimensions
100 mm x 75 um ID
Flow Rate
300 nL/min

Assay Multiplexing Expand assay panel

Broad Institute-Plasma-based Candidate Cancer Biomarkers

CPTAC-1372:
ALDOC.
ALQASALNAWR
CPTAC-1373:
ALDOC.
AEVNGLAAQGK
CPTAC-1374:
ALDOC.
ELSDIALR
CPTAC-1375:
ALDOC.
TPSALAILENANVLAR
CPTAC-1376:
ALDOC.
QVLFSADDR
CPTAC-1377:
ANXA1.
ALYEAGER
CPTAC-1378:
ANXA1.
GTDVNVFNTILTTR
CPTAC-1379:
ANXA1.
AAYLQETGKPLDETLK
CPTAC-1380:
ANXA1.
TPAQFDADELR
CPTAC-1381:
ANXA4.
VLVSLSAGGR
CPTAC-1382:
ANXA4.
GLGTDEDAIISVLAYR
CPTAC-1383:
ANXA4.
DEGNYLDDALVR
CPTAC-1384:
ANXA4.
GAGTDEGC[+57.0]LIEILASR
CPTAC-1385:
ANXA7.
LYQAGEGR
CPTAC-1386:
ANXA7.
SEIDLVQIK
CPTAC-1387:
ANXA7.
GAGTDDSTLVR
CPTAC-1388:
ANXA7.
EFSGYVESGLK
CPTAC-1389:
ANXA7.
GFGTDEQAIVDVVANR
CPTAC-1390:
CALR.
QIDNPDYK
CPTAC-1391:
CALR.
FYALSASFEPFSNK
CPTAC-1392:
CALR.
EQFLDGDGWTSR
CPTAC-1393:
CLIC1.
LHIVQVVC[+57.0]K
CPTAC-1394:
CLIC1.
YLSNAYAR
CPTAC-1395:
CLIC1.
IEEFLEAVLC[+57.0]PPR
CPTAC-1396:
CLIC1.
GVTFNVTTVDTK
CPTAC-1397:
CLIC1.
GFTIPEAFR
CPTAC-1398:
EZR.
IQVWHAEHR
CPTAC-1399:
EZR.
EDEVEEWQHR
CPTAC-1400:
EZR.
SGYLSSER
CPTAC-1401:
EZR.
IALLEEAR
CPTAC-1402:
EZR.
SQEQLAAELAEYTAK
CPTAC-1403:
FSCN1.
FLIVAHDDGR
CPTAC-1404:
FSCN1.
YLAPSGPSGTLK
CPTAC-1405:
FSCN1.
VTGTLDANR
CPTAC-1406:
FSCN1.
LSC[+57.0]FAQTVSPAEK
CPTAC-1407:
FTL.
LGGPEAGLGEYLFER
CPTAC-1408:
FTL.
KPAEDEWGK
CPTAC-1409:
FEN1.
SIEEIVR
CPTAC-1410:
FEN1.
QLQQAQAAGAEQEVEK
CPTAC-1411:
FEN1.
LIADVAPSAIR
CPTAC-1412:
GSTP1.
FQDGDLTLYQSNTILR
CPTAC-1413:
GSTP1.
EEVVTVETWQEGSLK
CPTAC-1414:
GSTP1.
PPYTVVYFPVR
CPTAC-1415:
GSTP1.
ASC[+57.0]LYGQLPK
CPTAC-1416:
GLO1.
FSLYFLAYEDK
CPTAC-1417:
GLO1.
SLDFYTR
CPTAC-1418:
GLO1.
IAWALSR
CPTAC-1419:
GLO1.
GFGHIGIAVPDVYSAC[+57.0]K
CPTAC-1420:
GLO1.
FEELGVK
CPTAC-1421:
GRB2.
FNSLNELVDYHR
CPTAC-1422:
GRB2.
FGNDVQHFK
CPTAC-1423:
GRB2.
NYVTPVNR
CPTAC-1424:
GRB2.
ATADDELSFK
CPTAC-1425:
GRB2.
ESESAPGDFSLSVK
CPTAC-1426:
HSPB1.
LFDQAFGLPR
CPTAC-1427:
HSPB1.
AQLGGPEAAK
CPTAC-1428:
HSPB1.
VSLDVNHFAPDELTVK
CPTAC-1429:
HSPB1.
DGVVEITGK
CPTAC-1430:
HSPB1.
QLSSGVSEIR
CPTAC-1431:
IL18.
EDELGDR
CPTAC-1432:
IL18.
SDIIFFQR
CPTAC-1433:
IL18.
TIFIISMYK
CPTAC-1434:
IL18.
ISTLSC[+57.0]ENK
CPTAC-1435:
IL18.
GMAVTISVK
CPTAC-1436:
LGALS1.
DGGAWGTEQR
CPTAC-1437:
LGALS1.
DSNNLC[+57.0]LHFNPR
CPTAC-1438:
LGALS1.
FNAHGDANTIVC[+57.0]NSK
CPTAC-1439:
LGALS1.
SFVLNLGK
CPTAC-1440:
LGALS1.
LPDGYEFK
CPTAC-1441:
PDLIM1.
C[+57.0]GTGIVGVFVK
CPTAC-1442:
PDLIM1.
VAASIGNAQK
CPTAC-1443:
PDLIM1.
VWSPLVTEEGK
CPTAC-1444:
PDLIM1.
DFEQPLAISR
CPTAC-1445:
PRDX2.
GLFIIDGK
CPTAC-1446:
PRDX2.
TDEGIAYR
CPTAC-1447:
PRDX2.
ATAVVDGAFK
CPTAC-1448:
PRDX4.
DYGVYLEDSGHTLR
CPTAC-1449:
PRDX4.
LVQAFQYTDK
CPTAC-1450:
PRDX4.
IPLLSDLTHQISK
CPTAC-1451:
PRDX4.
QITLNDLPVGR
CPTAC-1452:
S100A1.
ELLQTELSGFLDAQK
CPTAC-1453:
S100A2.
ELPSFVGEK
CPTAC-1454:
S100B.
AMVALIDVFHQYSGR
CPTAC-1455:
S100B.
ELINNELSHFLEEIK
CPTAC-1456:
RAD23B.
EQVIAALR
CPTAC-1457:
RAD23B.
IDIDPEETVK
CPTAC-1458:
RAD23B.
ILNDDTALK
CPTAC-1459:
SNCG.
EGVVGAVEK
CPTAC-1460:
SNCG.
ENVVQSVTSVAEK
CPTAC-1461:
SNCG.
TVEEAENIAVTSGVVR
CPTAC-1462:
TPM1.
LVIIESDLER
CPTAC-1463:
TPM1.
SIDDLEDELYAQK
CPTAC-1464:
TPM1.
QLEDELVSLQK
CPTAC-1465:
UBE2C.
YLQETYSK
CPTAC-1466:
UBE2C.
LSLEFPSGYPYNAPTVK
CPTAC-1467:
UBE2C.
DPAATSVAAAR
CPTAC-1468:
UBE2C.
GISAFPESDNLFK
CPTAC-1469:
UBE2I.
DDYPSSPPK
CPTAC-1470:
UBE2I.
DWRPAITIK
CPTAC-1471:
UBE2I.
DHPFGFVAVPTK

Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader

Repeatability

Data source: Panorama

  Average intra-assay CV
(within day CV)
Average inter-assay CV
(between day CV)
Total CV
equation
n=
Fragment ion / Transition Low Med High Low Med High Low Med High Low Med High
y6 (1+) 13.9 4.9 3.9 17.2 5.3 5.2 22.1 7.2 6.5 15 15 15
y7 (1+) 24.4 7.3 2.4 27.3 6.1 5.4 36.6 9.5 5.9 15 15 15
y8 (1+) 14.6 5.2 4.1 20.2 5.9 6.8 24.9 7.9 7.9 15 15 15
sum 14.1 2.6 2.7 17.6 3.9 5.3 22.6 4.7 5.9 15 15 15


Additional Resources and Comments


Assay Details for CPTAC-3248 Collapse assay details

Data source: Panorama

Official Gene Symbol
RAD23B
Peptide Sequence
IDIDPEETVK
Modification Type
unmodified
Protein - Site of Modification
N/A
Peptide - Site of Modification
N/A
Peptide Start
15
Peptide End
24
CPTAC ID
CPTAC-3248
Peptide Molecular Mass
1,157.5816
Species
Homo sapiens (Human)
Assay Type
Enrichment MRM
Enrichment Method
N/A
Matrix
cell lysate
Submitting Laboratory
Fred Hutchinson Cancer Research Center
Submitting Lab PI
Amanda Paulovich

Publication

View Details (opens in a new window)

A Multiplexed Mass Spectrometry-Based Assay for Robust Quantification of Phosphosignaling in Response to DNA Damage. Whiteaker JR, Zhao L, Saul R, Kaczmarczyk JA, Schoenherr RM, Moore HD, Jones-Weinert C, Ivey RG, Lin C, Hiltke T, Reding KW, Whiteley G, Wang P, Paulovich AG. Radiat Res. 2018 Feb 23. doi: 10.1667/RR14963.1. [Epub ahead of print]


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument
6500 QTRAP (Sciex)
Internal Standard
synthetic peptide
Peptide Standard Purity
>95%
Peptide Standard Label Type
13C and 15N at C-terminus K
LC
Ultra NanoLC 2D+ (Eksigent)
Column Packing
ReproSil-Pur C18-AQ 3um
Column Dimensions
100 x 0.075 mm
Flow Rate
300 uL/min

Assay Multiplexing Expand assay panel

Broad Institute-Plasma-based Candidate Cancer Biomarkers

CPTAC-1372:
ALDOC.
ALQASALNAWR
CPTAC-1373:
ALDOC.
AEVNGLAAQGK
CPTAC-1374:
ALDOC.
ELSDIALR
CPTAC-1375:
ALDOC.
TPSALAILENANVLAR
CPTAC-1376:
ALDOC.
QVLFSADDR
CPTAC-1377:
ANXA1.
ALYEAGER
CPTAC-1378:
ANXA1.
GTDVNVFNTILTTR
CPTAC-1379:
ANXA1.
AAYLQETGKPLDETLK
CPTAC-1380:
ANXA1.
TPAQFDADELR
CPTAC-1381:
ANXA4.
VLVSLSAGGR
CPTAC-1382:
ANXA4.
GLGTDEDAIISVLAYR
CPTAC-1383:
ANXA4.
DEGNYLDDALVR
CPTAC-1384:
ANXA4.
GAGTDEGC[+57.0]LIEILASR
CPTAC-1385:
ANXA7.
LYQAGEGR
CPTAC-1386:
ANXA7.
SEIDLVQIK
CPTAC-1387:
ANXA7.
GAGTDDSTLVR
CPTAC-1388:
ANXA7.
EFSGYVESGLK
CPTAC-1389:
ANXA7.
GFGTDEQAIVDVVANR
CPTAC-1390:
CALR.
QIDNPDYK
CPTAC-1391:
CALR.
FYALSASFEPFSNK
CPTAC-1392:
CALR.
EQFLDGDGWTSR
CPTAC-1393:
CLIC1.
LHIVQVVC[+57.0]K
CPTAC-1394:
CLIC1.
YLSNAYAR
CPTAC-1395:
CLIC1.
IEEFLEAVLC[+57.0]PPR
CPTAC-1396:
CLIC1.
GVTFNVTTVDTK
CPTAC-1397:
CLIC1.
GFTIPEAFR
CPTAC-1398:
EZR.
IQVWHAEHR
CPTAC-1399:
EZR.
EDEVEEWQHR
CPTAC-1400:
EZR.
SGYLSSER
CPTAC-1401:
EZR.
IALLEEAR
CPTAC-1402:
EZR.
SQEQLAAELAEYTAK
CPTAC-1403:
FSCN1.
FLIVAHDDGR
CPTAC-1404:
FSCN1.
YLAPSGPSGTLK
CPTAC-1405:
FSCN1.
VTGTLDANR
CPTAC-1406:
FSCN1.
LSC[+57.0]FAQTVSPAEK
CPTAC-1407:
FTL.
LGGPEAGLGEYLFER
CPTAC-1408:
FTL.
KPAEDEWGK
CPTAC-1409:
FEN1.
SIEEIVR
CPTAC-1410:
FEN1.
QLQQAQAAGAEQEVEK
CPTAC-1411:
FEN1.
LIADVAPSAIR
CPTAC-1412:
GSTP1.
FQDGDLTLYQSNTILR
CPTAC-1413:
GSTP1.
EEVVTVETWQEGSLK
CPTAC-1414:
GSTP1.
PPYTVVYFPVR
CPTAC-1415:
GSTP1.
ASC[+57.0]LYGQLPK
CPTAC-1416:
GLO1.
FSLYFLAYEDK
CPTAC-1417:
GLO1.
SLDFYTR
CPTAC-1418:
GLO1.
IAWALSR
CPTAC-1419:
GLO1.
GFGHIGIAVPDVYSAC[+57.0]K
CPTAC-1420:
GLO1.
FEELGVK
CPTAC-1421:
GRB2.
FNSLNELVDYHR
CPTAC-1422:
GRB2.
FGNDVQHFK
CPTAC-1423:
GRB2.
NYVTPVNR
CPTAC-1424:
GRB2.
ATADDELSFK
CPTAC-1425:
GRB2.
ESESAPGDFSLSVK
CPTAC-1426:
HSPB1.
LFDQAFGLPR
CPTAC-1427:
HSPB1.
AQLGGPEAAK
CPTAC-1428:
HSPB1.
VSLDVNHFAPDELTVK
CPTAC-1429:
HSPB1.
DGVVEITGK
CPTAC-1430:
HSPB1.
QLSSGVSEIR
CPTAC-1431:
IL18.
EDELGDR
CPTAC-1432:
IL18.
SDIIFFQR
CPTAC-1433:
IL18.
TIFIISMYK
CPTAC-1434:
IL18.
ISTLSC[+57.0]ENK
CPTAC-1435:
IL18.
GMAVTISVK
CPTAC-1436:
LGALS1.
DGGAWGTEQR
CPTAC-1437:
LGALS1.
DSNNLC[+57.0]LHFNPR
CPTAC-1438:
LGALS1.
FNAHGDANTIVC[+57.0]NSK
CPTAC-1439:
LGALS1.
SFVLNLGK
CPTAC-1440:
LGALS1.
LPDGYEFK
CPTAC-1441:
PDLIM1.
C[+57.0]GTGIVGVFVK
CPTAC-1442:
PDLIM1.
VAASIGNAQK
CPTAC-1443:
PDLIM1.
VWSPLVTEEGK
CPTAC-1444:
PDLIM1.
DFEQPLAISR
CPTAC-1445:
PRDX2.
GLFIIDGK
CPTAC-1446:
PRDX2.
TDEGIAYR
CPTAC-1447:
PRDX2.
ATAVVDGAFK
CPTAC-1448:
PRDX4.
DYGVYLEDSGHTLR
CPTAC-1449:
PRDX4.
LVQAFQYTDK
CPTAC-1450:
PRDX4.
IPLLSDLTHQISK
CPTAC-1451:
PRDX4.
QITLNDLPVGR
CPTAC-1452:
S100A1.
ELLQTELSGFLDAQK
CPTAC-1453:
S100A2.
ELPSFVGEK
CPTAC-1454:
S100B.
AMVALIDVFHQYSGR
CPTAC-1455:
S100B.
ELINNELSHFLEEIK
CPTAC-1456:
RAD23B.
EQVIAALR
CPTAC-1457:
RAD23B.
IDIDPEETVK
CPTAC-1458:
RAD23B.
ILNDDTALK
CPTAC-1459:
SNCG.
EGVVGAVEK
CPTAC-1460:
SNCG.
ENVVQSVTSVAEK
CPTAC-1461:
SNCG.
TVEEAENIAVTSGVVR
CPTAC-1462:
TPM1.
LVIIESDLER
CPTAC-1463:
TPM1.
SIDDLEDELYAQK
CPTAC-1464:
TPM1.
QLEDELVSLQK
CPTAC-1465:
UBE2C.
YLQETYSK
CPTAC-1466:
UBE2C.
LSLEFPSGYPYNAPTVK
CPTAC-1467:
UBE2C.
DPAATSVAAAR
CPTAC-1468:
UBE2C.
GISAFPESDNLFK
CPTAC-1469:
UBE2I.
DDYPSSPPK
CPTAC-1470:
UBE2I.
DWRPAITIK
CPTAC-1471:
UBE2I.
DHPFGFVAVPTK

Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader

Repeatability

Data source: Panorama

  Average intra-assay CV
(within day CV)
Average inter-assay CV
(between day CV)
Total CV
equation
n=
Fragment ion / Transition Low Med High Low Med High Low Med High Low Med High
y8 (1+) 23.5 10.4 12.8 26 11.1 11.3 35 15.2 17.1 15 15 15
y7 (1+) 21.3 14.4 13.2 23.7 14.8 13.8 31.9 20.6 19.1 15 15 15
y6 (1+) 23.1 13.4 11.2 25.7 14.6 10.7 34.6 19.8 15.5 15 15 15
sum 16.1 8 9.9 19.9 8.6 8.4 25.6 11.7 13 15 15 15


Additional Resources and Comments


Assay Details for CPTAC-723 Collapse assay details

Data source: Panorama

Official Gene Symbol
RAD23B
Peptide Sequence
ILNDDTALK
Modification Type
unmodified
Protein - Site of Modification
N/A
Peptide - Site of Modification
N/A
Peptide Start
52
Peptide End
60
CPTAC ID
CPTAC-723
Peptide Molecular Mass
1,001.5393
Species
Homo sapiens (Human)
Assay Type
Enrichment MRM
Enrichment Method
N/A
Matrix
plasma
Submitting Laboratory
Fred Hutchinson Cancer Research Center
Submitting Lab PI
Amanda Paulovich

Publication

View Details (opens in a new window)

Anti-peptide monoclonal antibodies generated for immuno-multiple reaction monitoring-mass spectrometry assays have a high probability of supporting Western blot and ELISA. Schoenherr RM, Saul RG, Whiteaker JR, Yan P, Whiteley GR, Paulovich AG. Mol Cell Proteomics. 2015 Feb;14(2):382-98. doi: 10.1074/mcp.O114.043133. Epub 2014 Dec 15. PMID: 25512614


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument
5500 Qtrap
Internal Standard
synthetic peptide
Peptide Standard Purity
>95%
Peptide Standard Label Type
13C and 15N at C-terminus K
LC
Eksigent NanoLC 2D
Column Packing
ReproSil-Pur C18-AQ 3 um
Column Dimensions
100 mm x 75 um ID
Flow Rate
300 nL/min

Assay Multiplexing Expand assay panel

Broad Institute-Plasma-based Candidate Cancer Biomarkers

CPTAC-1372:
ALDOC.
ALQASALNAWR
CPTAC-1373:
ALDOC.
AEVNGLAAQGK
CPTAC-1374:
ALDOC.
ELSDIALR
CPTAC-1375:
ALDOC.
TPSALAILENANVLAR
CPTAC-1376:
ALDOC.
QVLFSADDR
CPTAC-1377:
ANXA1.
ALYEAGER
CPTAC-1378:
ANXA1.
GTDVNVFNTILTTR
CPTAC-1379:
ANXA1.
AAYLQETGKPLDETLK
CPTAC-1380:
ANXA1.
TPAQFDADELR
CPTAC-1381:
ANXA4.
VLVSLSAGGR
CPTAC-1382:
ANXA4.
GLGTDEDAIISVLAYR
CPTAC-1383:
ANXA4.
DEGNYLDDALVR
CPTAC-1384:
ANXA4.
GAGTDEGC[+57.0]LIEILASR
CPTAC-1385:
ANXA7.
LYQAGEGR
CPTAC-1386:
ANXA7.
SEIDLVQIK
CPTAC-1387:
ANXA7.
GAGTDDSTLVR
CPTAC-1388:
ANXA7.
EFSGYVESGLK
CPTAC-1389:
ANXA7.
GFGTDEQAIVDVVANR
CPTAC-1390:
CALR.
QIDNPDYK
CPTAC-1391:
CALR.
FYALSASFEPFSNK
CPTAC-1392:
CALR.
EQFLDGDGWTSR
CPTAC-1393:
CLIC1.
LHIVQVVC[+57.0]K
CPTAC-1394:
CLIC1.
YLSNAYAR
CPTAC-1395:
CLIC1.
IEEFLEAVLC[+57.0]PPR
CPTAC-1396:
CLIC1.
GVTFNVTTVDTK
CPTAC-1397:
CLIC1.
GFTIPEAFR
CPTAC-1398:
EZR.
IQVWHAEHR
CPTAC-1399:
EZR.
EDEVEEWQHR
CPTAC-1400:
EZR.
SGYLSSER
CPTAC-1401:
EZR.
IALLEEAR
CPTAC-1402:
EZR.
SQEQLAAELAEYTAK
CPTAC-1403:
FSCN1.
FLIVAHDDGR
CPTAC-1404:
FSCN1.
YLAPSGPSGTLK
CPTAC-1405:
FSCN1.
VTGTLDANR
CPTAC-1406:
FSCN1.
LSC[+57.0]FAQTVSPAEK
CPTAC-1407:
FTL.
LGGPEAGLGEYLFER
CPTAC-1408:
FTL.
KPAEDEWGK
CPTAC-1409:
FEN1.
SIEEIVR
CPTAC-1410:
FEN1.
QLQQAQAAGAEQEVEK
CPTAC-1411:
FEN1.
LIADVAPSAIR
CPTAC-1412:
GSTP1.
FQDGDLTLYQSNTILR
CPTAC-1413:
GSTP1.
EEVVTVETWQEGSLK
CPTAC-1414:
GSTP1.
PPYTVVYFPVR
CPTAC-1415:
GSTP1.
ASC[+57.0]LYGQLPK
CPTAC-1416:
GLO1.
FSLYFLAYEDK
CPTAC-1417:
GLO1.
SLDFYTR
CPTAC-1418:
GLO1.
IAWALSR
CPTAC-1419:
GLO1.
GFGHIGIAVPDVYSAC[+57.0]K
CPTAC-1420:
GLO1.
FEELGVK
CPTAC-1421:
GRB2.
FNSLNELVDYHR
CPTAC-1422:
GRB2.
FGNDVQHFK
CPTAC-1423:
GRB2.
NYVTPVNR
CPTAC-1424:
GRB2.
ATADDELSFK
CPTAC-1425:
GRB2.
ESESAPGDFSLSVK
CPTAC-1426:
HSPB1.
LFDQAFGLPR
CPTAC-1427:
HSPB1.
AQLGGPEAAK
CPTAC-1428:
HSPB1.
VSLDVNHFAPDELTVK
CPTAC-1429:
HSPB1.
DGVVEITGK
CPTAC-1430:
HSPB1.
QLSSGVSEIR
CPTAC-1431:
IL18.
EDELGDR
CPTAC-1432:
IL18.
SDIIFFQR
CPTAC-1433:
IL18.
TIFIISMYK
CPTAC-1434:
IL18.
ISTLSC[+57.0]ENK
CPTAC-1435:
IL18.
GMAVTISVK
CPTAC-1436:
LGALS1.
DGGAWGTEQR
CPTAC-1437:
LGALS1.
DSNNLC[+57.0]LHFNPR
CPTAC-1438:
LGALS1.
FNAHGDANTIVC[+57.0]NSK
CPTAC-1439:
LGALS1.
SFVLNLGK
CPTAC-1440:
LGALS1.
LPDGYEFK
CPTAC-1441:
PDLIM1.
C[+57.0]GTGIVGVFVK
CPTAC-1442:
PDLIM1.
VAASIGNAQK
CPTAC-1443:
PDLIM1.
VWSPLVTEEGK
CPTAC-1444:
PDLIM1.
DFEQPLAISR
CPTAC-1445:
PRDX2.
GLFIIDGK
CPTAC-1446:
PRDX2.
TDEGIAYR
CPTAC-1447:
PRDX2.
ATAVVDGAFK
CPTAC-1448:
PRDX4.
DYGVYLEDSGHTLR
CPTAC-1449:
PRDX4.
LVQAFQYTDK
CPTAC-1450:
PRDX4.
IPLLSDLTHQISK
CPTAC-1451:
PRDX4.
QITLNDLPVGR
CPTAC-1452:
S100A1.
ELLQTELSGFLDAQK
CPTAC-1453:
S100A2.
ELPSFVGEK
CPTAC-1454:
S100B.
AMVALIDVFHQYSGR
CPTAC-1455:
S100B.
ELINNELSHFLEEIK
CPTAC-1456:
RAD23B.
EQVIAALR
CPTAC-1457:
RAD23B.
IDIDPEETVK
CPTAC-1458:
RAD23B.
ILNDDTALK
CPTAC-1459:
SNCG.
EGVVGAVEK
CPTAC-1460:
SNCG.
ENVVQSVTSVAEK
CPTAC-1461:
SNCG.
TVEEAENIAVTSGVVR
CPTAC-1462:
TPM1.
LVIIESDLER
CPTAC-1463:
TPM1.
SIDDLEDELYAQK
CPTAC-1464:
TPM1.
QLEDELVSLQK
CPTAC-1465:
UBE2C.
YLQETYSK
CPTAC-1466:
UBE2C.
LSLEFPSGYPYNAPTVK
CPTAC-1467:
UBE2C.
DPAATSVAAAR
CPTAC-1468:
UBE2C.
GISAFPESDNLFK
CPTAC-1469:
UBE2I.
DDYPSSPPK
CPTAC-1470:
UBE2I.
DWRPAITIK
CPTAC-1471:
UBE2I.
DHPFGFVAVPTK

Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader

Repeatability

Data source: Panorama

  Average intra-assay CV
(within day CV)
Average inter-assay CV
(between day CV)
Total CV
equation
n=
Fragment ion / Transition Low Med High Low Med High Low Med High Low Med High
y8 (2+) 57 31.1 7.1 72.3 28.9 7.5 92.1 42.5 10.3 15 15 15
y4 (1+) 61.4 25.8 11 65.6 27.4 10.5 89.9 37.6 15.2 15 15 15
y5 (1+) 33 29 7 54.5 31.6 6.6 63.7 42.9 9.6 15 15 15
y8 (1+) 18.6 6.2 2.9 14.7 5 2.8 23.7 8 4 15 15 15
sum 18.8 5.1 2.1 28 5.2 2.3 33.7 7.3 3.1 15 15 15


Additional Resources and Comments


Assay Details for CPTAC-3249 Collapse assay details

Data source: Panorama

Official Gene Symbol
RAD23B
Peptide Sequence
ILNDDTALK
Modification Type
unmodified
Protein - Site of Modification
N/A
Peptide - Site of Modification
N/A
Peptide Start
52
Peptide End
60
CPTAC ID
CPTAC-3249
Peptide Molecular Mass
1,001.5393
Species
Homo sapiens (Human)
Assay Type
Enrichment MRM
Enrichment Method
N/A
Matrix
cell lysate
Submitting Laboratory
Fred Hutchinson Cancer Research Center
Submitting Lab PI
Amanda Paulovich

Publication

View Details (opens in a new window)

A Multiplexed Mass Spectrometry-Based Assay for Robust Quantification of Phosphosignaling in Response to DNA Damage. Whiteaker JR, Zhao L, Saul R, Kaczmarczyk JA, Schoenherr RM, Moore HD, Jones-Weinert C, Ivey RG, Lin C, Hiltke T, Reding KW, Whiteley G, Wang P, Paulovich AG. Radiat Res. 2018 Feb 23. doi: 10.1667/RR14963.1. [Epub ahead of print]


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument
6500 QTRAP (Sciex)
Internal Standard
synthetic peptide
Peptide Standard Purity
>95%
Peptide Standard Label Type
13C and 15N at C-terminus K
LC
Ultra NanoLC 2D+ (Eksigent)
Column Packing
ReproSil-Pur C18-AQ 3um
Column Dimensions
100 x 0.075 mm
Flow Rate
300 uL/min

Assay Multiplexing Expand assay panel

Broad Institute-Plasma-based Candidate Cancer Biomarkers

CPTAC-1372:
ALDOC.
ALQASALNAWR
CPTAC-1373:
ALDOC.
AEVNGLAAQGK
CPTAC-1374:
ALDOC.
ELSDIALR
CPTAC-1375:
ALDOC.
TPSALAILENANVLAR
CPTAC-1376:
ALDOC.
QVLFSADDR
CPTAC-1377:
ANXA1.
ALYEAGER
CPTAC-1378:
ANXA1.
GTDVNVFNTILTTR
CPTAC-1379:
ANXA1.
AAYLQETGKPLDETLK
CPTAC-1380:
ANXA1.
TPAQFDADELR
CPTAC-1381:
ANXA4.
VLVSLSAGGR
CPTAC-1382:
ANXA4.
GLGTDEDAIISVLAYR
CPTAC-1383:
ANXA4.
DEGNYLDDALVR
CPTAC-1384:
ANXA4.
GAGTDEGC[+57.0]LIEILASR
CPTAC-1385:
ANXA7.
LYQAGEGR
CPTAC-1386:
ANXA7.
SEIDLVQIK
CPTAC-1387:
ANXA7.
GAGTDDSTLVR
CPTAC-1388:
ANXA7.
EFSGYVESGLK
CPTAC-1389:
ANXA7.
GFGTDEQAIVDVVANR
CPTAC-1390:
CALR.
QIDNPDYK
CPTAC-1391:
CALR.
FYALSASFEPFSNK
CPTAC-1392:
CALR.
EQFLDGDGWTSR
CPTAC-1393:
CLIC1.
LHIVQVVC[+57.0]K
CPTAC-1394:
CLIC1.
YLSNAYAR
CPTAC-1395:
CLIC1.
IEEFLEAVLC[+57.0]PPR
CPTAC-1396:
CLIC1.
GVTFNVTTVDTK
CPTAC-1397:
CLIC1.
GFTIPEAFR
CPTAC-1398:
EZR.
IQVWHAEHR
CPTAC-1399:
EZR.
EDEVEEWQHR
CPTAC-1400:
EZR.
SGYLSSER
CPTAC-1401:
EZR.
IALLEEAR
CPTAC-1402:
EZR.
SQEQLAAELAEYTAK
CPTAC-1403:
FSCN1.
FLIVAHDDGR
CPTAC-1404:
FSCN1.
YLAPSGPSGTLK
CPTAC-1405:
FSCN1.
VTGTLDANR
CPTAC-1406:
FSCN1.
LSC[+57.0]FAQTVSPAEK
CPTAC-1407:
FTL.
LGGPEAGLGEYLFER
CPTAC-1408:
FTL.
KPAEDEWGK
CPTAC-1409:
FEN1.
SIEEIVR
CPTAC-1410:
FEN1.
QLQQAQAAGAEQEVEK
CPTAC-1411:
FEN1.
LIADVAPSAIR
CPTAC-1412:
GSTP1.
FQDGDLTLYQSNTILR
CPTAC-1413:
GSTP1.
EEVVTVETWQEGSLK
CPTAC-1414:
GSTP1.
PPYTVVYFPVR
CPTAC-1415:
GSTP1.
ASC[+57.0]LYGQLPK
CPTAC-1416:
GLO1.
FSLYFLAYEDK
CPTAC-1417:
GLO1.
SLDFYTR
CPTAC-1418:
GLO1.
IAWALSR
CPTAC-1419:
GLO1.
GFGHIGIAVPDVYSAC[+57.0]K
CPTAC-1420:
GLO1.
FEELGVK
CPTAC-1421:
GRB2.
FNSLNELVDYHR
CPTAC-1422:
GRB2.
FGNDVQHFK
CPTAC-1423:
GRB2.
NYVTPVNR
CPTAC-1424:
GRB2.
ATADDELSFK
CPTAC-1425:
GRB2.
ESESAPGDFSLSVK
CPTAC-1426:
HSPB1.
LFDQAFGLPR
CPTAC-1427:
HSPB1.
AQLGGPEAAK
CPTAC-1428:
HSPB1.
VSLDVNHFAPDELTVK
CPTAC-1429:
HSPB1.
DGVVEITGK
CPTAC-1430:
HSPB1.
QLSSGVSEIR
CPTAC-1431:
IL18.
EDELGDR
CPTAC-1432:
IL18.
SDIIFFQR
CPTAC-1433:
IL18.
TIFIISMYK
CPTAC-1434:
IL18.
ISTLSC[+57.0]ENK
CPTAC-1435:
IL18.
GMAVTISVK
CPTAC-1436:
LGALS1.
DGGAWGTEQR
CPTAC-1437:
LGALS1.
DSNNLC[+57.0]LHFNPR
CPTAC-1438:
LGALS1.
FNAHGDANTIVC[+57.0]NSK
CPTAC-1439:
LGALS1.
SFVLNLGK
CPTAC-1440:
LGALS1.
LPDGYEFK
CPTAC-1441:
PDLIM1.
C[+57.0]GTGIVGVFVK
CPTAC-1442:
PDLIM1.
VAASIGNAQK
CPTAC-1443:
PDLIM1.
VWSPLVTEEGK
CPTAC-1444:
PDLIM1.
DFEQPLAISR
CPTAC-1445:
PRDX2.
GLFIIDGK
CPTAC-1446:
PRDX2.
TDEGIAYR
CPTAC-1447:
PRDX2.
ATAVVDGAFK
CPTAC-1448:
PRDX4.
DYGVYLEDSGHTLR
CPTAC-1449:
PRDX4.
LVQAFQYTDK
CPTAC-1450:
PRDX4.
IPLLSDLTHQISK
CPTAC-1451:
PRDX4.
QITLNDLPVGR
CPTAC-1452:
S100A1.
ELLQTELSGFLDAQK
CPTAC-1453:
S100A2.
ELPSFVGEK
CPTAC-1454:
S100B.
AMVALIDVFHQYSGR
CPTAC-1455:
S100B.
ELINNELSHFLEEIK
CPTAC-1456:
RAD23B.
EQVIAALR
CPTAC-1457:
RAD23B.
IDIDPEETVK
CPTAC-1458:
RAD23B.
ILNDDTALK
CPTAC-1459:
SNCG.
EGVVGAVEK
CPTAC-1460:
SNCG.
ENVVQSVTSVAEK
CPTAC-1461:
SNCG.
TVEEAENIAVTSGVVR
CPTAC-1462:
TPM1.
LVIIESDLER
CPTAC-1463:
TPM1.
SIDDLEDELYAQK
CPTAC-1464:
TPM1.
QLEDELVSLQK
CPTAC-1465:
UBE2C.
YLQETYSK
CPTAC-1466:
UBE2C.
LSLEFPSGYPYNAPTVK
CPTAC-1467:
UBE2C.
DPAATSVAAAR
CPTAC-1468:
UBE2C.
GISAFPESDNLFK
CPTAC-1469:
UBE2I.
DDYPSSPPK
CPTAC-1470:
UBE2I.
DWRPAITIK
CPTAC-1471:
UBE2I.
DHPFGFVAVPTK

Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader

Repeatability

Data source: Panorama

  Average intra-assay CV
(within day CV)
Average inter-assay CV
(between day CV)
Total CV
equation
n=
Fragment ion / Transition Low Med High Low Med High Low Med High Low Med High
y5 (1+) 44.1 17.6 11.2 49.9 18.7 12.1 66.6 25.7 16.5 15 15 15
y8 (2+) 28.6 16.3 14.7 47.8 14.6 16 55.7 21.9 21.7 15 15 15
y4 (1+) 38.8 17.8 11.2 38.3 19 17.4 54.5 26 20.7 15 15 15
y7 (1+) 5.4 5.8 6.4 8.6 10.6 6.6 10.2 12.1 9.2 15 15 15
y6 (1+) 20.2 12.8 11.9 37.5 13.1 14.4 42.6 18.3 18.7 15 15 15
y8 (1+) 24.2 7.8 7.3 26.8 10.5 8.7 36.1 13.1 11.4 15 15 15
sum 8.7 3.8 6.2 10.2 7.8 6.4 13.4 8.7 8.9 15 15 15


Additional Resources and Comments


Assay Details for non-CPTAC-3607 Collapse assay details

Data source: Panorama

Official Gene Symbol
Rad23b
Peptide Sequence
ILSDDTALK
Modification Type
unmodified
Protein - Site of Modification
N/A
Peptide - Site of Modification
N/A
Peptide Start
52
Peptide End
60
CPTAC ID
non-CPTAC-3607
Peptide Molecular Mass
974.5284
Species
Mus musculus (Mouse)
Assay Type
Direct MRM
Matrix
Plasma
Submitting Laboratory
UVic-Genome BC Proteomics Centre
Submitting Lab PI
Christoph Borchers

Publication

View Details (opens in a new window)

Molecular phenotyping of laboratory mouse strains using 500 multiple reaction monitoring mass spectrometry plasma assays. Michaud SA, Sinclair NJ, Petrošová H, Palmer AL, Pistawka AJ, Zhang S, Hardie DB, Mohammed Y Eshghi A1, Richard VR, Sickmann A, Borchers CH. Commun Biol. 2018 Jun 27;1:78. doi: 10.1038/s42003-018-0087-6. eCollection 2018.


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument
Agilent 6490/6495 QQQ
Internal Standard
synthetic peptide
Peptide Standard Purity
>95%
Peptide Standard Label Type
13C and 15N at C-terminus K
LC
1290 LC (Agilent)
Column Packing
Zorbax Eclipse Plus C18, 1.8 µm
Column Dimensions
2.1 x 150 mm
Flow Rate
400 µL/min

Assay Multiplexing Expand assay panel

Broad Institute-Plasma-based Candidate Cancer Biomarkers

CPTAC-1372:
ALDOC.
ALQASALNAWR
CPTAC-1373:
ALDOC.
AEVNGLAAQGK
CPTAC-1374:
ALDOC.
ELSDIALR
CPTAC-1375:
ALDOC.
TPSALAILENANVLAR
CPTAC-1376:
ALDOC.
QVLFSADDR
CPTAC-1377:
ANXA1.
ALYEAGER
CPTAC-1378:
ANXA1.
GTDVNVFNTILTTR
CPTAC-1379:
ANXA1.
AAYLQETGKPLDETLK
CPTAC-1380:
ANXA1.
TPAQFDADELR
CPTAC-1381:
ANXA4.
VLVSLSAGGR
CPTAC-1382:
ANXA4.
GLGTDEDAIISVLAYR
CPTAC-1383:
ANXA4.
DEGNYLDDALVR
CPTAC-1384:
ANXA4.
GAGTDEGC[+57.0]LIEILASR
CPTAC-1385:
ANXA7.
LYQAGEGR
CPTAC-1386:
ANXA7.
SEIDLVQIK
CPTAC-1387:
ANXA7.
GAGTDDSTLVR
CPTAC-1388:
ANXA7.
EFSGYVESGLK
CPTAC-1389:
ANXA7.
GFGTDEQAIVDVVANR
CPTAC-1390:
CALR.
QIDNPDYK
CPTAC-1391:
CALR.
FYALSASFEPFSNK
CPTAC-1392:
CALR.
EQFLDGDGWTSR
CPTAC-1393:
CLIC1.
LHIVQVVC[+57.0]K
CPTAC-1394:
CLIC1.
YLSNAYAR
CPTAC-1395:
CLIC1.
IEEFLEAVLC[+57.0]PPR
CPTAC-1396:
CLIC1.
GVTFNVTTVDTK
CPTAC-1397:
CLIC1.
GFTIPEAFR
CPTAC-1398:
EZR.
IQVWHAEHR
CPTAC-1399:
EZR.
EDEVEEWQHR
CPTAC-1400:
EZR.
SGYLSSER
CPTAC-1401:
EZR.
IALLEEAR
CPTAC-1402:
EZR.
SQEQLAAELAEYTAK
CPTAC-1403:
FSCN1.
FLIVAHDDGR
CPTAC-1404:
FSCN1.
YLAPSGPSGTLK
CPTAC-1405:
FSCN1.
VTGTLDANR
CPTAC-1406:
FSCN1.
LSC[+57.0]FAQTVSPAEK
CPTAC-1407:
FTL.
LGGPEAGLGEYLFER
CPTAC-1408:
FTL.
KPAEDEWGK
CPTAC-1409:
FEN1.
SIEEIVR
CPTAC-1410:
FEN1.
QLQQAQAAGAEQEVEK
CPTAC-1411:
FEN1.
LIADVAPSAIR
CPTAC-1412:
GSTP1.
FQDGDLTLYQSNTILR
CPTAC-1413:
GSTP1.
EEVVTVETWQEGSLK
CPTAC-1414:
GSTP1.
PPYTVVYFPVR
CPTAC-1415:
GSTP1.
ASC[+57.0]LYGQLPK
CPTAC-1416:
GLO1.
FSLYFLAYEDK
CPTAC-1417:
GLO1.
SLDFYTR
CPTAC-1418:
GLO1.
IAWALSR
CPTAC-1419:
GLO1.
GFGHIGIAVPDVYSAC[+57.0]K
CPTAC-1420:
GLO1.
FEELGVK
CPTAC-1421:
GRB2.
FNSLNELVDYHR
CPTAC-1422:
GRB2.
FGNDVQHFK
CPTAC-1423:
GRB2.
NYVTPVNR
CPTAC-1424:
GRB2.
ATADDELSFK
CPTAC-1425:
GRB2.
ESESAPGDFSLSVK
CPTAC-1426:
HSPB1.
LFDQAFGLPR
CPTAC-1427:
HSPB1.
AQLGGPEAAK
CPTAC-1428:
HSPB1.
VSLDVNHFAPDELTVK
CPTAC-1429:
HSPB1.
DGVVEITGK
CPTAC-1430:
HSPB1.
QLSSGVSEIR
CPTAC-1431:
IL18.
EDELGDR
CPTAC-1432:
IL18.
SDIIFFQR
CPTAC-1433:
IL18.
TIFIISMYK
CPTAC-1434:
IL18.
ISTLSC[+57.0]ENK
CPTAC-1435:
IL18.
GMAVTISVK
CPTAC-1436:
LGALS1.
DGGAWGTEQR
CPTAC-1437:
LGALS1.
DSNNLC[+57.0]LHFNPR
CPTAC-1438:
LGALS1.
FNAHGDANTIVC[+57.0]NSK
CPTAC-1439:
LGALS1.
SFVLNLGK
CPTAC-1440:
LGALS1.
LPDGYEFK
CPTAC-1441:
PDLIM1.
C[+57.0]GTGIVGVFVK
CPTAC-1442:
PDLIM1.
VAASIGNAQK
CPTAC-1443:
PDLIM1.
VWSPLVTEEGK
CPTAC-1444:
PDLIM1.
DFEQPLAISR
CPTAC-1445:
PRDX2.
GLFIIDGK
CPTAC-1446:
PRDX2.
TDEGIAYR
CPTAC-1447:
PRDX2.
ATAVVDGAFK
CPTAC-1448:
PRDX4.
DYGVYLEDSGHTLR
CPTAC-1449:
PRDX4.
LVQAFQYTDK
CPTAC-1450:
PRDX4.
IPLLSDLTHQISK
CPTAC-1451:
PRDX4.
QITLNDLPVGR
CPTAC-1452:
S100A1.
ELLQTELSGFLDAQK
CPTAC-1453:
S100A2.
ELPSFVGEK
CPTAC-1454:
S100B.
AMVALIDVFHQYSGR
CPTAC-1455:
S100B.
ELINNELSHFLEEIK
CPTAC-1456:
RAD23B.
EQVIAALR
CPTAC-1457:
RAD23B.
IDIDPEETVK
CPTAC-1458:
RAD23B.
ILNDDTALK
CPTAC-1459:
SNCG.
EGVVGAVEK
CPTAC-1460:
SNCG.
ENVVQSVTSVAEK
CPTAC-1461:
SNCG.
TVEEAENIAVTSGVVR
CPTAC-1462:
TPM1.
LVIIESDLER
CPTAC-1463:
TPM1.
SIDDLEDELYAQK
CPTAC-1464:
TPM1.
QLEDELVSLQK
CPTAC-1465:
UBE2C.
YLQETYSK
CPTAC-1466:
UBE2C.
LSLEFPSGYPYNAPTVK
CPTAC-1467:
UBE2C.
DPAATSVAAAR
CPTAC-1468:
UBE2C.
GISAFPESDNLFK
CPTAC-1469:
UBE2I.
DDYPSSPPK
CPTAC-1470:
UBE2I.
DWRPAITIK
CPTAC-1471:
UBE2I.
DHPFGFVAVPTK

Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader

Repeatability

Data source: Panorama

  Average intra-assay CV
(within day CV)
Average inter-assay CV
(between day CV)
Total CV
equation
n=
Fragment ion / Transition Low Med High Low Med High Low Med High Low Med High
b4 (2+) 93.3 105.8 86.1 79.6 128.5 162.6 122.6 166.5 184 15 15 15
b2 (1+) 7.1 3.7 4.9 8.6 7.6 6.4 11.2 8.5 8.1 15 15 15
y2 (1+) 24.8 12.7 7.2 21.9 21.4 8.8 33.1 24.9 11.4 15 15 15
y7 (1+) 8.7 3.2 4.6 9.6 8.1 6.3 13 8.7 7.8 15 15 15
y8 (1+) 10.6 4.5 4.4 14.4 10.7 7.6 17.9 11.6 8.8 15 15 15
sum 5 2.4 2.7 7 8.2 3.5 8.6 8.5 4.4 15 15 15


Additional Resources and Comments